Dianthus Therapeutics | MGTA - Zysk Brutto Na Sprzedaży

Cena Akcji
61.55
Dzienna Zmiana
6.16 11.12%
Miesięcznie
32.14%
Rocznie
170.43%
Q1 Prognozy TE
53.50




Zysk Brutto Na Sprzedaży Zmiana Data
Akebia Therapeutics USD 49.21M 13.25M 2025-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Cspc Pharmaceutical CNY 4.34B 333.68M 2025-09
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 44.83M 9.96M 2025-06
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD 226M 583M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 31.84M 23.88M 2025-09
Organon & Co USD 854M 3M 2025-12
Pharma Mar EUR 86.7M 53.34M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 67.63M 15.62M 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 63.38M 3.74M 2025-09
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06